Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1033 of 1,261
  1. US 7537791

    Parthenolide free bioactive ingredients from feverfew (Tanacetum parthenium) and processes for their production

    INTEGRATED BOTANICAL TECHNOLOGIES, LLC · Granted May 26, 2009 · Expires May 21, 2029

    granted
  2. US 7538108

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  3. US 7537759

    Modulating angiogenesis

    The Regents of the University of California · Granted May 26, 2009 · Expires May 21, 2029

    granted
  4. US 7537421

    Dead spindle PTO with compliant grounding mechanism

    BLACK & DECKER INC. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  5. US 7538183

    HPV vaccine comprising peptides from host cell proteins

    University College Cardiff Consultants Limited · Granted May 26, 2009 · Expires May 21, 2029

    granted
  6. US 7538189

    Methods of making deuterated cyclosporin analogs

    Isotechnika, Inc. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  7. US 7538136

    Crystalline forms of atorvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 26, 2009 · Expires May 21, 2029

    granted
  8. US 7538129

    Diazonamide A analog

    The Board of Regents of the University of Texas System · Granted May 26, 2009 · Expires May 21, 2029

    granted
  9. US 7534440

    Fusion molecules and methods for treatment of immune diseases

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  10. US 7534868

    Human antibodies to human delta like ligand 4

    REGENERON PHARMACEUTICALS, INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  11. US 7534859

    Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  12. US 7534887

    Thiazoline derivative and use of the same

    Takeda Pharmaceutical Company Limited · Granted May 19, 2009 · Expires May 14, 2029

    granted
  13. US 7534913

    Crystalline form of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  14. US 7534900

    Process for the purification of duloxetine hydrochloride

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  15. US 7534889

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  16. US 7534604

    Fusion polypeptides capable of activating receptors

    REGENERON PHARMACEUTICALS, INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  17. US 7534595

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  18. US 7534565

    DLC-1 gene deleted in cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted May 19, 2009 · Expires May 14, 2029

    granted
  19. US 7534775

    Methods and compositions for modulating cardiac contractility

    Sangamo Biosciences, Inc. · Granted May 19, 2009 · Expires May 14, 2029

    granted
  20. US 7534418

    Imaging agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 19, 2009 · Expires May 14, 2029

    granted
  21. US 7534764

    Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  22. US 7534761

    Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom

    Northwestern University · Granted May 19, 2009 · Expires May 14, 2029

    granted
  23. US 7534613

    Methods of treating parkinson's disease using viral vectors

    The Regents of the University of California · Granted May 19, 2009 · Expires May 14, 2029

    granted
  24. AR 065042

    DERIVADOS DE CINNOLINA, PROCESOS DE OBTENCION Y COMPOSICIONES FARMACEUTICAS

    ASTRAZENECA AB [SE] · Granted May 13, 2009 · Expires May 8, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.